English | Español
Jamie Barrand | Feb 13, 2016

Enrollment complete for genetic-based biomarker risk assignment algorithm trial
Jamie Barrand | Feb 13, 2016

AbbVie introduces scholarship for students with rheumatological conditions
Jamie Barrand | Feb 13, 2016

'The Lancet' publishes trial results for anti-cancer agent
Jamie Barrand | Feb 13, 2016

University of Michigan, AstraZeneca partner on chronic kidney disease consortium
Jamie Barrand | Feb 13, 2016

Sandoz acquires infliximab inhibitor treatment from Pfizer
Jamie Barrand | Feb 11, 2016

BIO officials oppose funding cuts in president's proposed 2017 budget
Jamie Barrand | Feb 11, 2016

Trial results positive for possible endometriosis therapy
Jamie Barrand | Feb 11, 2016

Panel discusses challenges of electronic health records

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’